Chronic Disease Self-management Program for Hypertension Control in Churches
CHIC
Assessing Effectiveness of a Chronic Disease Self-management Program in Faith-based Organizations in Barbados: a Cluster Randomized Trial
1 other identifier
interventional
384
1 country
1
Brief Summary
In Barbados, levels of hypertension are high (40.7%) and cause of a high proportion of deaths due to cardiovascular diseases. In this study, the Stanford University-led Chronic Disease Self-Management Program (CDSMP) will be modified to form one of the basic components of a three-pronged intervention to improve blood pressure control. Our overall goal is to evaluate the effectiveness of a hypertension self-management program in community-based settings. With the advent of the Coronavirus disease 2019 (COVID-19) we recognize that it may be necessary to adapt the programme to accommodate virtual delivery. Our specific aims are to:
- 1.Adapt the Stanford (CDSMP) to ensure cultural appropriateness to Barbados. In view of the need to adhere to physical distance guidelines in the era of COVID-19 disease, modifications will be made to enhance virtual delivery while maintaining programme fidelity. We will engage stakeholders in performing modifications related to content, context and mode of delivery of the CDSMP program with the goal of ensuring cultural appropriateness.
- 2.Determine the clinical effectiveness of CDSMP combined with medication enhancement tools. We will conduct a cluster randomized trial in twelve faith-based organizations(FBOs) in Barbados. We are primarily interested in studying the changes in systolic blood pressure. Secondarily, we will also assess change in weight, medication adherence, dietary behavior and physical activity.
- 3.Understand the barriers and facilitators to implementation and sustainability of CDSMP plus self-monitoring tools in faith-based organizations. We will assess cost and sustainability of the intervention and qualitatively assess factors associated with barriers and facilitators of implementation in FBOs in Barbados.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2020
CompletedFirst Posted
Study publicly available on registry
June 18, 2020
CompletedStudy Start
First participant enrolled
October 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJune 24, 2021
June 1, 2021
12 months
June 11, 2020
June 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Systolic blood pressure
We will measure systolic blood pressure before and 6 months after the interventions
Six months
Secondary Outcomes (4)
Mean weight change for intervention and control groups
Six months
Level of adherence to the Dietary Approaches to Stop Hypertension (DASH) Diet
Six months
Assessing physical activity levels using the Global Physical Activity Questionnaire (GPAQ)
Six months
Self-Efficacy for Managing Chronic Diseases 6-item Scale
Six months
Study Arms (2)
Self-management Group
EXPERIMENTALThe intervention consists of three levels - (1) chronic disease self-management workshops, (2) distribution of and teaching on the use of medication pill boxes and (3) use of social media (WhatsApp version 2.0) to encourage medication adherence. We combine the Stanford Chronic Disease Self-Management Curriculum, add medication adherence tools and social media use to develop a novel intervention aimed at better blood pressure control. The CDSMP focuses on enhancing skills through problem solving and brainstorming activities. In the workshop we discuss: blood pressure control, finding and affording healthy foods, label reading, physical activity, planning a healthy plate, making traditional foods healthy and portion control. Pill boxes will be distributed to all individuals in the intervention group. Post workshop, participants will be sent twice weekly reminders to use their high blood pressure medications via the social media tool WhatsApp. These will be sent for one month.
Usual care group
NO INTERVENTIONControls will receive educational material at baseline and one didactic session (on importance of medication adherence to hypertension control) lasting 1 hour delivered by a health care professional.
Interventions
CDSMP workshops will last for approximately 2.5 hours and occur weekly for six weeks. Sessions will focus on appropriate diet for persons with hypertension and to facilitate weight loss; managing medications, adherence to medical clinic appointments; physical activity and stress management. Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management program. Participants will also be given pill boxes and will be prompted by social media messages to make and keep clinic appointments as well as maintain a healthy lifestyle.
Eligibility Criteria
You may qualify if:
- Resident in Barbados for the previous six months
- No plans to migrate over the ensuing one year.
- All persons with a previous diagnosis of hypertension or currently on anti- hypertensives AND the occurrence of two or more blood pressure readings above 140 mmHg (systolic) or 90mmHg (diastolic) on the day of recruitment will be deemed eligible.
- Persons not known to have hypertension but who have two or more blood pressure readings above 140 mmHg (systolic) or 90mmHg (diastolic) on the day of recruitment are also eligible
You may not qualify if:
- Non-residents of Barbados
- Persons whose systolic blood pressure is below 140mmHg AND/OR diastolic blood pressure below 90mmHg
- Persons who are pregnant of planning to become pregnant over the following nine months
- Unwillingness/inability to comply with the study protocol
- Current participation in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
George Alleyne Chronic Disease Research Centre
Bridgetown, BB15000, Barbados
Related Publications (1)
Sobers NP, Hambleton IR, Hassan S, Anderson SG, Brathwaite-Graham L, Lewis K, Ferguson TS. Assessing the effectiveness and implementation of a chronic disease self-management programme in faith-based organisations in Barbados: protocol for a cluster randomised parallel trial. BMJ Open. 2021 Oct 4;11(10):e050548. doi: 10.1136/bmjopen-2021-050548.
PMID: 34607863DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Natasha P Sobers, PhD
George Alleyne Chronic Disease Research Centre
- STUDY DIRECTOR
Lisa Brathwaite-Graham, MPH
George Alleyne Chronic Disease Research Centre
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Data collectors will be blinded to church randomization status until the end of the six-week recruitment period.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer, Epidemiology
Study Record Dates
First Submitted
June 11, 2020
First Posted
June 18, 2020
Study Start
October 11, 2020
Primary Completion
October 1, 2021
Study Completion
December 1, 2021
Last Updated
June 24, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The data will become available two years after the study analysis is complete.
- Access Criteria
- IPD will only be shared if the absolute number of participants is greater than 20. There will be grouping of variables (such as exact age) that may contribute to "potential identifiability" of participants. Researchers will be given the option of contact with PI to use original dataset for approved research purposes.
De-identified individual participant data (IPD) will be shared, with standard removal of identifiable information (list the variables) and with de-identification of all dates by random shifting. All IPD that underlie results in a publication will be shared.